These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 18632268)
1. Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptase. Sweeney ZK; Dunn JP; Li Y; Heilek G; Dunten P; Elworthy TR; Han X; Harris SF; Hirschfeld DR; Hogg JH; Huber W; Kaiser AC; Kertesz DJ; Kim W; Mirzadegan T; Roepel MG; Saito YD; Silva TM; Swallow S; Tracy JL; Villasenor A; Vora H; Zhou AS; Klumpp K Bioorg Med Chem Lett; 2008 Aug; 18(15):4352-4. PubMed ID: 18632268 [TBL] [Abstract][Full Text] [Related]
2. Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptase. Sweeney ZK; Acharya S; Briggs A; Dunn JP; Elworthy TR; Fretland J; Giannetti AM; Heilek G; Li Y; Kaiser AC; Martin M; Saito YD; Smith M; Suh JM; Swallow S; Wu J; Hang JQ; Zhou AS; Klumpp K Bioorg Med Chem Lett; 2008 Aug; 18(15):4348-51. PubMed ID: 18625554 [TBL] [Abstract][Full Text] [Related]
3. Diphenyl ether non-nucleoside reverse transcriptase inhibitors with excellent potency against resistant mutant viruses and promising pharmacokinetic properties. Sweeney ZK; Kennedy-Smith JJ; Wu J; Arora N; Billedeau JR; Davidson JP; Fretland J; Hang JQ; Heilek GM; Harris SF; Hirschfeld D; Inbar P; Javanbakht H; Jernelius JA; Jin Q; Li Y; Liang W; Roetz R; Sarma K; Smith M; Stefanidis D; Su G; Suh JM; Villaseñor AG; Welch M; Zhang FJ; Klumpp K ChemMedChem; 2009 Jan; 4(1):88-99. PubMed ID: 19006142 [TBL] [Abstract][Full Text] [Related]
4. Design of annulated pyrazoles as inhibitors of HIV-1 reverse transcriptase. Sweeney ZK; Harris SF; Arora SF; Javanbakht H; Li Y; Fretland J; Davidson JP; Billedeau JR; Gleason SK; Hirschfeld D; Kennedy-Smith JJ; Mirzadegan T; Roetz R; Smith M; Sperry S; Suh JM; Wu J; Tsing S; Villaseñor AG; Paul A; Su G; Heilek G; Hang JQ; Zhou AS; Jernelius JA; Zhang FJ; Klumpp K J Med Chem; 2008 Dec; 51(23):7449-58. PubMed ID: 19007201 [TBL] [Abstract][Full Text] [Related]
5. Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1. Chan JH; Freeman GA; Tidwell JH; Romines KR; Schaller LT; Cowan JR; Gonzales SS; Lowell GS; Andrews CW; Reynolds DJ; St Clair M; Hazen RJ; Ferris RG; Creech KL; Roberts GB; Short SA; Weaver K; Koszalka GW; Boone LR J Med Chem; 2004 Feb; 47(5):1175-82. PubMed ID: 14971897 [TBL] [Abstract][Full Text] [Related]
6. N1-Heterocyclic pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Mitchell ML; Son JC; Lee IY; Lee CK; Kim HS; Guo H; Wang J; Hayes J; Wang M; Paul A; Lansdon EB; Chen JM; Eisenberg G; Geleziunas R; Xu L; Kim CU Bioorg Med Chem Lett; 2010 Mar; 20(5):1585-8. PubMed ID: 20137928 [TBL] [Abstract][Full Text] [Related]
7. Discovery of 3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): a potent, orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitor with improved potency against key mutant viruses. Tucker TJ; Sisko JT; Tynebor RM; Williams TM; Felock PJ; Flynn JA; Lai MT; Liang Y; McGaughey G; Liu M; Miller M; Moyer G; Munshi V; Perlow-Poehnelt R; Prasad S; Reid JC; Sanchez R; Torrent M; Vacca JP; Wan BL; Yan Y J Med Chem; 2008 Oct; 51(20):6503-11. PubMed ID: 18826204 [TBL] [Abstract][Full Text] [Related]
8. Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1. Hopkins AL; Ren J; Milton J; Hazen RJ; Chan JH; Stuart DI; Stammers DK J Med Chem; 2004 Nov; 47(24):5912-22. PubMed ID: 15537346 [TBL] [Abstract][Full Text] [Related]
10. Non-nucleoside HIV-1 reverse transcriptase inhibitors di-halo-indolyl aryl sulfones achieve tight binding to drug-resistant mutants by targeting the enzyme-substrate complex. Samuele A; Kataropoulou A; Viola M; Zanoli S; La Regina G; Piscitelli F; Silvestri R; Maga G Antiviral Res; 2009 Jan; 81(1):47-55. PubMed ID: 18984007 [TBL] [Abstract][Full Text] [Related]
11. Optimization of 5-aryloxyimidazole non-nucleoside reverse transcriptase inhibitors. Jones LH; Allan G; Corbau R; Hay D; Middleton DS; Mowbray CE; Newman SD; Perros M; Randall A; Vuong H; Webster R; Westby M; Williams D ChemMedChem; 2008 Nov; 3(11):1756-62. PubMed ID: 18855969 [TBL] [Abstract][Full Text] [Related]
12. Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains. Himmel DM; Das K; Clark AD; Hughes SH; Benjahad A; Oumouch S; Guillemont J; Coupa S; Poncelet A; Csoka I; Meyer C; Andries K; Nguyen CH; Grierson DS; Arnold E J Med Chem; 2005 Dec; 48(24):7582-91. PubMed ID: 16302798 [TBL] [Abstract][Full Text] [Related]
13. Studies of nonnucleoside HIV-1 reverse transcriptase inhibitors. Part 1: Design and synthesis of thiazolidenebenzenesulfonamides. Masuda N; Yamamoto O; Fujii M; Ohgami T; Fujiyasu J; Kontani T; Moritomo A; Orita M; Kurihara H; Koga H; Nakahara H; Kageyama S; Ohta M; Inoue H; Hatta T; Suzuki H; Sudo K; Shimizu Y; Kodama E; Matsuoka M; Fujiwara M; Yokota T; Shigeta S; Baba M Bioorg Med Chem; 2004 Dec; 12(23):6171-82. PubMed ID: 15519161 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1. Wu B; Kuhen K; Ngoc Nguyen T; Ellis D; Anaclerio B; He X; Yang K; Karanewsky D; Yin H; Wolff K; Bieza K; Caldwell J; He Y Bioorg Med Chem Lett; 2006 Jul; 16(13):3430-3. PubMed ID: 16632349 [TBL] [Abstract][Full Text] [Related]
15. Discovery of piperidin-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-benzyl derivatives with broad potency against resistant mutant viruses. Kertesz DJ; Brotherton-Pleiss C; Yang M; Wang Z; Lin X; Qiu Z; Hirschfeld DR; Gleason S; Mirzadegan T; Dunten PW; Harris SF; Villaseñor AG; Hang JQ; Heilek GM; Klumpp K Bioorg Med Chem Lett; 2010 Jul; 20(14):4215-8. PubMed ID: 20538456 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIs. Li D; Zhan P; Liu H; Pannecouque C; Balzarini J; De Clercq E; Liu X Bioorg Med Chem; 2013 Apr; 21(7):2128-34. PubMed ID: 23415090 [TBL] [Abstract][Full Text] [Related]
17. Novel modifications in the series of O-(2-phthalimidoethyl)-N-substituted thiocarbamates and their ring-opened congeners as non-nucleoside HIV-1 reverse transcriptase inhibitors. Spallarossa A; Cesarini S; Ranise A; Bruno O; Schenone S; La Colla P; Collu G; Sanna G; Secci B; Loddo R Eur J Med Chem; 2009 Apr; 44(4):1650-63. PubMed ID: 18954921 [TBL] [Abstract][Full Text] [Related]
18. Pyrazole NNRTIs 1: design and initial optimisation of a novel template. Mowbray CE; Burt C; Corbau R; Perros M; Tran I; Stupple PA; Webster R; Wood A Bioorg Med Chem Lett; 2009 Oct; 19(19):5599-602. PubMed ID: 19709880 [TBL] [Abstract][Full Text] [Related]
19. Slow-, tight-binding HIV-1 reverse transcriptase non-nucleoside inhibitors highly active against drug-resistant mutants. Cancio R; Mai A; Rotili D; Artico M; Sbardella G; Clotet-Codina I; Esté JA; Crespan E; Zanoli S; Hübscher U; Spadari S; Maga G ChemMedChem; 2007 Apr; 2(4):445-8. PubMed ID: 17323401 [No Abstract] [Full Text] [Related]
20. Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptase. Ren J; Stammers DK Virus Res; 2008 Jun; 134(1-2):157-70. PubMed ID: 18313784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]